The TRI Story
Read about the importance of collaboration between science and clinic and how it was the catalyst for establishing TRI, and the innovation and impact created since opening in 2012.
The TRI Story
The TRI Building
Explore our award-winning, purpose-built institute and the world-class facilities to understand why so many researchers and biomedical organisations call it home.
The TRI Building
Countdown to 2026
TRI’s translational manufacturing facility will become Australia’s first scale-up biomedical cGMP facility for high-potential biomedical startups. Set to attract a range of innovators, and positioned within Queensland’s newest knowledge corridor, it is already experiencing high pre-opening demand.
Our unique biomedical cGMP model will provide expertise, specialist equipment, resourcing and support services normally out of reach for startups. It will deliver new diagnostics, medical devices and therapies with real-world impacts.
Express your interest
Bright Sparqs of the Future
Immerse yourself in the SPARQ-ed experience!
Join students from across Queensland in our full-equipped PC2 lab and help a researcher solve a real-world problem and advance your STEM leadership aspirations.
Transforming young biotechs into global leaders
By basing their business at TRI, biomedical technology (biotech) companies in the early stages of research and product development gain access to our state-of-the-art facilities, technology and resources. This provides a safety net and time to translate their innovation into products that will have life-changing impacts on our populations.
Facilities
TRI Core Facilities provide access to world-class capabilities for researchers and clinicians at the interface of science, medicine, and industry.
As part of TRI’s unique precinct, our highly specialised Core Facility equipment, staff, and emerging technologies are designed to support and create opportunities for advancing medical research.
TRI ACTIVATE
Matching industry and scientists for research collaborations
TRI ACTIVATE is a program matching researchers with industry to explore new collaborations in developing medical therapeutics, diagnostics and devices.
This highly anticipated event will be held again in 2025.